CN102145178A - Peg化白介素15 - Google Patents
Peg化白介素15 Download PDFInfo
- Publication number
- CN102145178A CN102145178A CN2011100956416A CN201110095641A CN102145178A CN 102145178 A CN102145178 A CN 102145178A CN 2011100956416 A CN2011100956416 A CN 2011100956416A CN 201110095641 A CN201110095641 A CN 201110095641A CN 102145178 A CN102145178 A CN 102145178A
- Authority
- CN
- China
- Prior art keywords
- rhil
- polyethylene glycol
- interleukin
- peg
- conjugates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
比活(U/mg) | 保留活性(%) | |
rhIL-15 | 2.0×107 | — |
mPEG10-rhIL-15 | 2.12×106 | 12.61 |
mPEG20-rhIL-15 | 1.25×106 | 9.25 |
mPEG40-rhIL-15 | 0.72×106 | 4.61 |
种类 | 平均达峰时间Tpeak | 平均消除半衰期(t1/2e) |
rhIL-15 | 8.4±1.63min | 22.1±1.19min |
mPEG20-rhIL-15 | 13.33±2.07h | 34.43±4.77h |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110095641A CN102145178B (zh) | 2011-04-15 | 2011-04-15 | Peg化白介素15 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110095641A CN102145178B (zh) | 2011-04-15 | 2011-04-15 | Peg化白介素15 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102145178A true CN102145178A (zh) | 2011-08-10 |
CN102145178B CN102145178B (zh) | 2012-09-26 |
Family
ID=44419777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110095641A Active CN102145178B (zh) | 2011-04-15 | 2011-04-15 | Peg化白介素15 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102145178B (zh) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014114262A1 (zh) * | 2013-01-28 | 2014-07-31 | 天津键凯科技有限公司 | 水溶性聚合物-氨基酸寡肽-药物结合物及其制备方法和用途 |
US9700633B2 (en) | 2013-01-28 | 2017-07-11 | Jenkem Technology Co., Ltd., Tianjin Branch | Conjugates of water soluble polymer-amino acid oligopeptide-drug, preparation method and use thereof |
US9823255B2 (en) | 2013-06-17 | 2017-11-21 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
US9943568B2 (en) | 2013-04-18 | 2018-04-17 | Armo Biosciences, Inc. | Methods of using pegylated interleukin-10 for treating cancer |
US10010588B2 (en) | 2013-08-30 | 2018-07-03 | Armo Biosciences, Inc. | Methods of using pegylated interleukin-10 for treating hyperlipidemia |
US10143726B2 (en) | 2014-10-22 | 2018-12-04 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
US10195274B2 (en) | 2015-05-28 | 2019-02-05 | Armo Biosciences Inc. | Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10 |
US10293043B2 (en) | 2014-06-02 | 2019-05-21 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
US10350270B2 (en) | 2014-10-14 | 2019-07-16 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
US10398761B2 (en) | 2015-08-25 | 2019-09-03 | Armo Biosciences, Inc. | Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers |
US20190290733A1 (en) * | 2015-03-11 | 2019-09-26 | Nektar Therapeutics | Conjugates of an il-7 moiety and a polymer |
US10618970B2 (en) | 2015-02-03 | 2020-04-14 | Armo Biosciences, Inc. | Method of treating cancer with IL-10 and antibodies that induce ADCC |
CN111093688A (zh) * | 2017-05-15 | 2020-05-01 | 尼克塔治疗公司 | 长效白细胞介素-15受体激动剂以及相关免疫治疗组合物和方法 |
US11413332B2 (en) | 2013-11-11 | 2022-08-16 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
CN115894660A (zh) * | 2021-09-30 | 2023-04-04 | 康立泰生物医药(青岛)有限公司 | 聚乙二醇衍生物修饰的白介素12及其制备方法和应用 |
WO2023133595A2 (en) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA39711A (fr) * | 2014-04-03 | 2015-10-08 | Nektar Therapeutics | Conjugués d'une fraction d'il-15 et d'un polymère |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101104078A (zh) * | 2006-07-11 | 2008-01-16 | 北京美倍他药物研究有限公司 | 多肽及蛋白药物的聚乙二醇偶合物 |
-
2011
- 2011-04-15 CN CN201110095641A patent/CN102145178B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101104078A (zh) * | 2006-07-11 | 2008-01-16 | 北京美倍他药物研究有限公司 | 多肽及蛋白药物的聚乙二醇偶合物 |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014114262A1 (zh) * | 2013-01-28 | 2014-07-31 | 天津键凯科技有限公司 | 水溶性聚合物-氨基酸寡肽-药物结合物及其制备方法和用途 |
US9700633B2 (en) | 2013-01-28 | 2017-07-11 | Jenkem Technology Co., Ltd., Tianjin Branch | Conjugates of water soluble polymer-amino acid oligopeptide-drug, preparation method and use thereof |
US9943568B2 (en) | 2013-04-18 | 2018-04-17 | Armo Biosciences, Inc. | Methods of using pegylated interleukin-10 for treating cancer |
US10357545B2 (en) | 2013-04-18 | 2019-07-23 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating solid tumors |
US9823255B2 (en) | 2013-06-17 | 2017-11-21 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
US10209261B2 (en) | 2013-06-17 | 2019-02-19 | Armo Biosciences Inc. | Method for assessing protein identity and stability |
US10010588B2 (en) | 2013-08-30 | 2018-07-03 | Armo Biosciences, Inc. | Methods of using pegylated interleukin-10 for treating hyperlipidemia |
US11413332B2 (en) | 2013-11-11 | 2022-08-16 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
US10293043B2 (en) | 2014-06-02 | 2019-05-21 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
US10350270B2 (en) | 2014-10-14 | 2019-07-16 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
US10653751B2 (en) | 2014-10-22 | 2020-05-19 | Armo Biosciences Inc. | Methods of treating cancer metastasis by using interleukin-10 |
US10143726B2 (en) | 2014-10-22 | 2018-12-04 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
US10618970B2 (en) | 2015-02-03 | 2020-04-14 | Armo Biosciences, Inc. | Method of treating cancer with IL-10 and antibodies that induce ADCC |
US20190290733A1 (en) * | 2015-03-11 | 2019-09-26 | Nektar Therapeutics | Conjugates of an il-7 moiety and a polymer |
US10195274B2 (en) | 2015-05-28 | 2019-02-05 | Armo Biosciences Inc. | Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10 |
US10398761B2 (en) | 2015-08-25 | 2019-09-03 | Armo Biosciences, Inc. | Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers |
CN111093688A (zh) * | 2017-05-15 | 2020-05-01 | 尼克塔治疗公司 | 长效白细胞介素-15受体激动剂以及相关免疫治疗组合物和方法 |
AU2018270926B2 (en) * | 2017-05-15 | 2022-04-07 | Nektar Therapeutics | Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods |
AU2018270926C1 (en) * | 2017-05-15 | 2022-10-27 | Nektar Therapeutics | Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods |
AU2022203691B2 (en) * | 2017-05-15 | 2023-10-12 | Nektar Therapeutics | Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods |
CN115894660A (zh) * | 2021-09-30 | 2023-04-04 | 康立泰生物医药(青岛)有限公司 | 聚乙二醇衍生物修饰的白介素12及其制备方法和应用 |
WO2023051801A1 (zh) * | 2021-09-30 | 2023-04-06 | 康立泰生物医药(青岛)有限公司 | 聚乙二醇衍生物修饰的白介素12及其制备方法和应用 |
CN115894660B (zh) * | 2021-09-30 | 2024-03-15 | 康立泰生物医药(青岛)有限公司 | 聚乙二醇衍生物修饰的白介素12及其制备方法和应用 |
WO2023133595A2 (en) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
Also Published As
Publication number | Publication date |
---|---|
CN102145178B (zh) | 2012-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102145178B (zh) | Peg化白介素15 | |
KR100203824B1 (ko) | 거핵구 성장 및 분화를 자극하기 위한 조성물 및방법 | |
JP3747070B2 (ja) | 改良型インターフェロン−ポリマーコンジュゲート | |
KR100689212B1 (ko) | Gcsf 결합체 | |
EP2049566B1 (en) | G-csf site-specific mono-conjugates | |
EP1037657B1 (en) | Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same | |
US20030166566A1 (en) | Chemically modified novel erythropoietin stimulating protein compositions and methods | |
CN102153643A (zh) | 粒细胞集落形成刺激因子(g-csf)的突变体及其化学缀合多肽 | |
CN103923209B (zh) | 一种Lambda干扰素突变体及聚乙二醇衍生物 | |
CN101584866A (zh) | 聚乙二醇修饰的人白介素-2、其制备方法及应用 | |
CN102453089B (zh) | 重组集成干扰素变异体聚乙二醇偶联物的制备和应用 | |
WO2020228791A1 (zh) | 增殖免疫细胞的il-2突变体蛋白 | |
CN101163716B (zh) | 白细胞介素-6聚乙二醇结合物及其制备方法和应用 | |
EP0422010A1 (en) | Combination therapy of il-2 and dtic for the treatment of melanoma | |
CN105085658B (zh) | 一种白细胞介素29突变体及聚乙二醇衍生物 | |
US20130109623A1 (en) | G-csf and water-soluble polymer conjugate | |
WO2011041376A1 (en) | Modified granulocyte colony stimulating factor (g-csf) | |
CN101376676B (zh) | 聚乙二醇化红细胞生成素蛋白长效制剂 | |
US20050281778A1 (en) | Human growth hormone conjugated with biocompatible polymer | |
CN101352573B (zh) | 聚乙二醇单修饰的重组人集落细胞刺激因子赖氨酸缺陷体 | |
CN105085657A (zh) | 一种干扰素突变体及聚乙二醇衍生物 | |
CN103933577B (zh) | 重组集成干扰素变异体聚乙二醇偶联物的制备和应用 | |
JPH03236400A (ja) | 化学修飾ポリペプチド及びその用途 | |
KR100888371B1 (ko) | 가지 달린 고분자 유도체와 인터페론 결합체를 포함하는 항바이러스제 | |
CN114920819A (zh) | 重组人生长激素突变体、其聚乙二醇衍生物、聚乙二醇衍生物的制备方法及其药物用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100176, 6, Jingdong street, Yizhuang economic and Technological Development Zone, Beijing, Daxing District Patentee after: BEIJING KAWIN TECHNOLOGY SHARE-HOLDING Co.,Ltd. Patentee after: Beijing Furui Tiancheng Biotechnology Co.,Ltd. Address before: 100176, 6, Jingdong street, Yizhuang economic and Technological Development Zone, Beijing, Daxing District Patentee before: BEIJING KAWIN TECHNOLOGY SHARE-HOLDING Co.,Ltd. Patentee before: BEIJING KAWIN BIOTECHNOLOGY Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING FURUI TIANCHENG BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20150203 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 100176, 6, Jingdong street, Yizhuang economic and Technological Development Zone, Beijing, Daxing District Patentee after: BEIJING KAWIN TECHNOLOGY SHARE-HOLDING Co.,Ltd. Patentee after: Beijing Furui Tiancheng Biotechnology Co.,Ltd. Address before: 100176, 6, Jingdong street, Yizhuang economic and Technological Development Zone, Beijing, Daxing District Patentee before: BEIJING KAWIN TECHNOLOGY SHARE-HOLDING Co.,Ltd. Patentee before: BEIJING KAWIN BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150203 Address after: 100176, 6, Jingdong street, Yizhuang economic and Technological Development Zone, Beijing, Daxing District Patentee after: BEIJING KAWIN TECHNOLOGY SHARE-HOLDING Co.,Ltd. Address before: 100176, 6, Jingdong street, Yizhuang economic and Technological Development Zone, Beijing, Daxing District Patentee before: BEIJING KAWIN TECHNOLOGY SHARE-HOLDING Co.,Ltd. Patentee before: Beijing Furui Tiancheng Biotechnology Co.,Ltd. |